Latest Articles

Publication Date
‘How I knew I had endometrial cancer’: Survivors share their stories - UT MD Anderson

‘How I knew I had endometrial cancer’: Survivors share their stories UT MD Anderson

Published: June 16, 2026, 7:05 p.m.
Endometrial Ablation Devices Market growth supported by rising - openPR.com

Endometrial Ablation Devices Market growth supported by rising openPR.com

Published: June 16, 2026, 5:58 a.m.
Endometrial cancer, Picardo (Acto Piemonte): "Dostarlimab offers more effective treatments for more women." - La Milano

Endometrial cancer, Picardo (Acto Piemonte): "Dostarlimab offers more effective treatments for more women." La Milano

Published: June 16, 2026, 5:13 a.m.
From Ovarian to Endometrial Cancer, Experts Spotlight Standout Data From ASCO 2026 - OncLive

From Ovarian to Endometrial Cancer, Experts Spotlight Standout Data From ASCO 2026 OncLive

Published: June 15, 2026, 12:06 p.m.
Interleukin-17A as a key driver for cell migration, proliferation, inflammation, and nerve infiltration in deep endometriosis.

Deep endometriosis (DE) is the most severe subtype of endometriosis, marked by aggressive cellular behavior and debilitating pain. However, the molecular mechanisms underlying DE pathogenesis remain poorly understood. In this …

Published: June 15, 2026, midnight
Endometrial Cancer, Sri Lanka’s Commonest Gynaecological Cancer - dailynews.lk

Endometrial Cancer, Sri Lanka’s Commonest Gynaecological Cancer dailynews.lk

Published: June 14, 2026, 7:42 p.m.
Mesenchymal Stem Cells Therapy for Intrauterine Adhesions and Endometriosis: Potential, Mechanisms, and Future Directions.

Intrauterine adhesions (IUA) and endometriosis are debilitating gynecological disorders that impair endometrial function and fertility. IUA, typically caused by iatrogenic trauma to the basal endometrium, leads to fibrosis and infertility, …

Published: June 14, 2026, midnight
RNF34 restrains endometriosis through SREBP1-dependent metabolic-immune crosstalk.

Endometriosis is a chronic inflammatory disease with cancer-like features, yet the mechanisms linking metabolic dysregulation to immune remodeling during lesion progression remain poorly understood. Here, we identify the ubiquitin E3 …

Published: June 13, 2026, midnight
Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data - TipRanks

Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data TipRanks

Published: June 11, 2026, 4:35 p.m.
Epithelial-Mesenchymal Transitional Markers in Endometrial Carcinoma: A Review of Clinicopathological Correlation - Cureus

Epithelial-Mesenchymal Transitional Markers in Endometrial Carcinoma: A Review of Clinicopathological Correlation Cureus

Published: June 11, 2026, 8:19 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!